Clinical Trials Directory

Trials / Completed

CompletedNCT04681651

Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

A Randomized Controlled Trial Assessing the Efficacy and Safety of Normobaric Hyperoxia for Acute Ischemic Stroke Patients Undergoing Endovascular Treatment

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
282 (actual)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The current endovascular treatment has increased the recanalization rate to more than 90%. Even so, the prognosis rate of stroke is still less than 50%. Our previous research confirmed that the neuroprotective effect of Normobaric Hyperoxia (NBO) from multiple perspectives. However, the clinical study on NBO was not satisfactory, which might be due to the absence of vascular recanalization therapy. Therefore, The investigators conducted this RCT study to further explore the Efficacy and safety of NBO combined with endovascular treatment in patients with acute ischemic stroke.

Conditions

Interventions

TypeNameDescription
DRUGNormobaric HyperoxiaWithin 6 hours after stroke onset, patients were randomized into the NBO group and immediately given 100% oxygen inhalation (no more than 30 minutes after randomization) at a ventilation rate of 10L/ min using a sealed non-ventilating oxygen storage mask and keep giving oxygen for 4 hours. If the patient needs to be intubated with a ventilator to maintain ventilation, the FiO2 should be set to 1.0.
DRUGSham Normobaric HyperoxiaFor Sham NBO group, Patients were immediately given oxygen inhalation (no more than 30 minutes after randomization) at a ventilation rate of 1l/min using the same mask and keep giving oxygen for 4 hours. If the patient needs to be intubated with a ventilator to maintain, the FiO2 should be set to 0.3 and gradualy incerased if spO2≤94%;
PROCEDUREEndovascular ThrombectomyEVT is the international guidelines for the treatment of acute ischemic stroke with lage vessel occlusion.

Timeline

Start date
2021-04-22
Primary completion
2023-05-05
Completion
2023-05-05
First posted
2020-12-23
Last updated
2023-07-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04681651. Inclusion in this directory is not an endorsement.